This article is based on clinical guidance from Martina Ziegenbein, MD, a board-certified rheumatologist and PRT-trained physician.
There is a question that comes up more than almost any other from people with fibromyalgia. Not "is this neuroplastic?" That part, most people have found a way to sit with. The question underneath it is harder:
My ANA came back positive. What if I have lupus?
My ESR or CRP was elevated. Doesn't that mean I have inflammation?
My X-ray wasn't completely normal. Could that be causing all of this pain?
These are reasonable questions. And they do not go away just because someone tells you not to worry about it. To move past them, it helps to understand what a rheumatologist is actually looking for, what common test results do and do not mean, and what a fibromyalgia diagnosis means.
The short answer is no. Fibromyalgia is not currently classified as an autoimmune disease, and it is not considered an inflammatory condition either.
Autoimmune diseases occur when the immune system mistakenly attacks the body's own healthy tissue. In conditions such as lupus, rheumatoid arthritis and Sjögren's disease, that immune activity can produce patterns of inflammation, tissue damage or organ involvement that clinicians evaluate through a person's symptoms, physical examination, blood work and sometimes imaging.
Fibromyalgia generally belongs on the non-inflammatory side of that picture.
And non-inflammatory absolutely does not mean mild.
People with fibromyalgia can experience severe and disabling pain, profound fatigue, brain fog, sleep problems and many other very real symptoms. What rheumatologists generally do not find is enough inflammation, tissue injury or organ damage to explain the severity and extent of those symptoms.
Fibromyalgia pain is commonly described as nociplastic pain. This means that pain is arising from altered nociception, or altered processing of signals related to pain, without clear evidence that ongoing tissue damage or a nerve lesion fully explains it. The symptoms are real, even when the primary mechanism is not inflammatory tissue damage.
Research into the biology of fibromyalgia continues to evolve. Some studies have explored possible immune dysregulation and antibody involvement in subsets of patients. These are active areas of investigation, but they have not changed the current clinical classification of fibromyalgia as a non-autoimmune condition.
Dr. Ziegenbein describes rheumatologists as a little like detectives.
When someone comes in with pain, fatigue, brain fog and symptoms that may not fit neatly together, one of the major questions a rheumatologist is trying to answer is: is there an inflammatory process causing these symptoms, or is there not?
She describes it as a fork in the road. On one side are inflammatory and autoimmune conditions in which the immune system is damaging the body's tissue. Treatment may involve medication that suppresses or modifies the immune response.
On the other side are conditions such as fibromyalgia, including fibromyalgia syndrome or FMS. The symptoms may be extensive and debilitating, but the overall clinical picture does not show the inflammation, tissue injury or organ involvement that would point toward a systemic autoimmune rheumatic disease.
A rheumatologist does not determine which side someone is on based on one test. They consider the pattern of symptoms, physical examination, laboratory results, imaging when appropriate and whether the complete picture fits a recognized disease.
When that evaluation does not find evidence of autoimmune disease, that is not the same as finding nothing. It is an answer.
The ANA test, which checks for antinuclear antibodies, is one of the most common sources of uncertainty for people with fibromyalgia.
A positive ANA can be associated with autoimmune diseases such as lupus, Sjögren's disease and systemic sclerosis. However, a positive ANA is not a diagnosis. Healthy people can have positive ANA results too. The meaning of the result also depends on factors such as the testing method, dilution threshold, antibody pattern and the reason the test was ordered.
When a rheumatologist sees a positive ANA, they do not stop there and diagnose an autoimmune disease. They look for the rest of the evidence:
Is there inflammatory arthritis or visible joint swelling?
Is there a characteristic rash?
Is there kidney involvement?
Is there inflammation around the heart or lungs?
Are there particular blood-count abnormalities or disease-specific antibodies?
Does the person's history and physical examination fit a recognized autoimmune pattern?
Research has found that positive ANA results are relatively common in healthy people and have limited predictive value when the clinical features of autoimmune disease are not present. One study found that approximately 13% of healthy individuals tested positive at a 1:80 dilution threshold. In a separate study of people referred to rheumatology solely because of a positive ANA, only 23.5% ultimately received a rheumatological diagnosis.
Fibromyalgia has no confirmatory test. There is no blood result or scan that says yes, this is it. The diagnosis is built on clinical pattern recognition: what the symptoms look like, how they behave over time, and what the evaluation ruled out. This can make fibromyalgia diagnosis feel frustrating, especially for people wondering about fibromyalgia symptoms like widespread pain, fatigue, and brain fog.
Sometimes, after all of that detective work, the answer really is: "Your ANA is positive, but I do not see evidence that you have lupus or another systemic autoimmune rheumatic disease."
That answer can be surprisingly difficult to live with because what you may hear is: they do not know what is wrong with me.
What your rheumatologist may actually be saying is: I see the abnormal test. I have considered what it could mean. I do not see the other evidence that would make this an autoimmune disease.
Those are very different statements.
Imaging frequently identifies changes such as arthritis, disc degeneration or other forms of wear and tear. These findings may matter, but their presence does not automatically mean they explain widespread pain, fatigue, brain fog and the full range of fibromyalgia symptoms.
Rheumatologists ask whether the location and extent of an imaging finding match the person's symptoms. They also consider whether it shows an inflammatory pattern, whether the physical examination supports it and whether it could reasonably account for the overall clinical picture.
An imaging result can be real without being the primary driver of every symptom. Fibromyalgia can also coexist with other conditions, so the goal is not to pretend that an X-ray finding does not exist. The goal is to understand what that finding can reasonably explain and what it cannot.
Unresolved uncertainty can function as an ongoing threat signal.
The nervous system is not a passive bystander in this process. We already know it can produce real, measurable physiological changes in everyday life: your face flushes when you are embarrassed, your skin breaks out when you are under stress. The same principle extends further than most people realize. IBS, migraines, and even the swelling seen in CRPS are all examples of the nervous system driving genuine physical changes in the body. A finding on a test does not automatically mean something is systemically wrong. Sometimes it means the nervous system has been under sustained pressure for a long time.
The nervous system also does not wait for perfect information before deciding whether something is dangerous. If part of you is still asking, what if something serious was missed, your system may continue scanning for evidence of danger.
Research specific to fibromyalgia helps make this concrete. One study of 51 women with fibromyalgia found that greater illness uncertainty was associated with more difficulty coping with increases in pain. Another study of 138 women with fibromyalgia found that illness uncertainty was associated with poorer well-being, with helplessness making that relationship stronger.
This does not mean uncertainty caused the original condition or that someone is hurting because they are worrying too much. It means that unanswered diagnostic questions can add to the nervous system's overall threat load.
A person who hears "Your ANA is positive, but here is what that means and what we looked for" may be in a very different position from someone who leaves an appointment feeling as if something could still be lurking. A clear medical explanation is not empty reassurance. It can change the conditions the nervous system is working with.
Medicine rarely offers complete certainty.
You may have a positive ANA that cannot be fully explained. Your ESR or CRP may have been mildly elevated. Your imaging may show some wear and tear. You may have symptoms that do not fit perfectly into one box.
That does not mean you must keep searching before it is safe to begin working with the nervous system.
If you have been appropriately evaluated and diagnosed with fibromyalgia, you can begin approaching your symptoms through a neuroplastic lens while continuing appropriate medical care and follow-up. Many people find that fibromyalgia treatment through a nervous system approach, rather than purely medication-based fibromyalgia treatment options, opens doors that traditional care did not.
Pain Reprocessing Therapy does not require you to declare that nothing else could ever be wrong. It does not ask you to dismiss concerning test results or ignore new or changing symptoms. It does not require absolute certainty.
PRT helps the nervous system reconsider its assessment of danger. Part of that work is recognizing that not every uncertainty can be resolved, but enough clarity can exist to move forward.
Fibromyalgia is one of the conditions that frequently brings people to PRT. Sometimes the barrier is not disbelief in the neuroplastic framework. It is the lingering fear that the framework does not account for everything that is happening.
A thorough medical evaluation and clear explanation can help address the unanswered medical question. And when the nervous system does begin to feel safe, the physiological changes it drove can reverse. Patients who have had elevated markers for years watch them normalize. Swelling that seemed structural turns out to be reversible. The body is not broken. It was responding to a signal, and when the signal changes, the response changes with it.
People with fibromyalgia and anxiety, fibromyalgia and depression, or fibromyalgia and sleep problems often find this especially relevant, since all of these are expressions of the same nervous system dysregulation.
PRT can then help you change the fear, vigilance and threat associations that have developed around the pain itself.
If you are ready to work with a provider who understands fibromyalgia through a nervous system lens,
WellBody Psychotherapy specializes in Pain Reprocessing Therapy and related approaches and is accepting new patients.
Dr. Martina Ziegenbein, a board-certified rheumatologist and PRT-trained physician, hosted a free one-hour webinar about fibromyalgia, abnormal test results and the fear that something has been missed.
She explains how rheumatologists evaluate chronic pain, distinguish inflammatory disease from fibromyalgia and interpret the blood tests and imaging findings that often leave patients with questions. The recording includes a live Q&A.
If the "but what if something was missed" question has been sitting with you, this conversation is worth your time.
There is no universally agreed-upon cure for fibromyalgia, but many people experience significant reduction or remission of symptoms, particularly when working with the nervous system directly through approaches like PRT.
People with fibromyalgia commonly describe widespread musculoskeletal pain, profound fatigue, brain fog, sleep disturbances, and heightened sensitivity to touch, light, and sound.
Fibromyalgia can be severely disabling for some people and mild for others. Its impact on daily function varies widely.
No. Fibromyalgia does not produce abnormal findings on standard blood tests or imaging. The diagnosis is made clinically based on symptom patterns after other conditions have been ruled out.
Lupus is an autoimmune disease that causes measurable inflammation and can damage organs. Fibromyalgia is a nociplastic pain condition without inflammatory tissue damage. They can be distinguished through clinical evaluation and specific laboratory tests.
Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Häuser W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021;397(10289):2098-2110. doi:10.1016/S0140-6736(21)00392-5.
Clauw DJ. From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here? Annals of the Rheumatic Diseases. 2024;83(11):1421-1427. doi:10.1136/ard-2023-225327.
Tan EM, Feltkamp TEW, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis & Rheumatism. 1997;40(9):1601-1611. doi:10.1002/art.1780400909.
Chu CS, Ho LY, Mok CC. Prediction of a positive ANA result for a rheumatological diagnosis in an outpatient setting. Journal of Clinical Rheumatology and Immunology. 2023;23(1):46-50. doi:10.1142/S2661341723500025.
Johnson LM, Zautra AJ, Davis MC. The role of illness uncertainty on coping with fibromyalgia symptoms. Health Psychology. 2006;25(6):696-703. doi:10.1037/0278-6133.25.6.696.
Reibel MD, Hutti MH. The role of helplessness in the appraisal of illness uncertainty in women with fibromyalgia. Nursing Science Quarterly. 2020;33(4):346-352. doi:10.1177/0894318420943151.
